Figlin RA - Search Results

1

Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.

Belldegrun A, Shvarts O, Figlin RA. Belldegrun A, et al. Among authors: figlin ra. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S88-92. Cancer J Sci Am. 2000. PMID: 10685666

2

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.

Figlin RA, Belldegrun A, Moldawer N, Zeffren J, deKernion J. Figlin RA, et al. J Clin Oncol. 1992 Mar;10(3):414-21. doi: 10.1200/JCO.1992.10.3.414. J Clin Oncol. 1992. PMID: 1482425 Clinical Trial.

3

Immunotherapy for renal cell carcinoma.

Belldegrun A, Figlin R, Danella J, deKernion J. Belldegrun A, et al. Semin Urol. 1992 Feb;10(1):23-7. Semin Urol. 1992. PMID: 1565900 Review.

4

The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.

Figlin RA, Abi-Aad AS, Belldegrun A, deKernion JB. Figlin RA, et al. Semin Oncol. 1991 Oct;18(5 Suppl 7):102-7. Semin Oncol. 1991. PMID: 1719641 Review.

5

Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection.

Abi-Aad AS, Figlin RA, Belldegrun A, deKernion JB. Abi-Aad AS, et al. Among authors: figlin ra. J Immunother (1991). 1991 Aug;10(4):292-5. J Immunother (1991). 1991. PMID: 1931865

6

Renal cell carcinoma: basic biology and current approaches to therapy.

Belldegrun A, Abi-Aad AS, Figlin RA, deKernion JB. Belldegrun A, et al. Among authors: figlin ra. Semin Oncol. 1991 Oct;18(5 Suppl 7):96-101. Semin Oncol. 1991. PMID: 1948136 Review.

7

Atypical contrast reactions associated with systemic interleukin-2 therapy.

Fishman JE, Aberle DR, Moldawer NP, Belldegrun A, Figlin RA. Fishman JE, et al. Among authors: figlin ra. AJR Am J Roentgenol. 1991 Apr;156(4):833-4. doi: 10.2214/ajr.156.4.2003450. AJR Am J Roentgenol. 1991. PMID: 2003450 No abstract available.

8

Immunotherapy for advanced renal cell cancer: the role of radical nephrectomy.

Belldegrun A, Koo AS, Bochner B, Figlin R, deKernion JB. Belldegrun A, et al. Eur Urol. 1990;18 Suppl 2:42-5. doi: 10.1159/000463962. Eur Urol. 1990. PMID: 2226609 No abstract available.

9

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J. Ganz PA, et al. Among authors: figlin ra. Cancer. 1989 Apr 1;63(7):1271-8. doi: 10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>3.0.co;2-6. Cancer. 1989. PMID: 2465815 Clinical Trial.

10

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.

Figlin RA, deKernion JB, Mukamel E, Palleroni AV, Itri LM, Sarna GP. Figlin RA, et al. J Clin Oncol. 1988 Oct;6(10):1604-10. doi: 10.1200/JCO.1988.6.10.1604. J Clin Oncol. 1988. PMID: 3049952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters